Commonwealth Equity Services’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11K | Buy |
34,948
+348
| +1% | +$110 | ﹤0.01% | 4231 |
|
2025
Q1 | $10K | Hold |
34,600
| – | – | ﹤0.01% | 4148 |
|
2024
Q4 | $12K | Sell |
34,600
-10,000
| -22% | -$3.47K | ﹤0.01% | 4064 |
|
2024
Q3 | $19K | Buy |
44,600
+10,000
| +29% | +$4.26K | ﹤0.01% | 3999 |
|
2024
Q2 | $15K | Buy |
+34,600
| New | +$15K | ﹤0.01% | 3981 |
|
2023
Q4 | – | Sell |
-165,490
| Closed | -$59K | – | 3962 |
|
2023
Q3 | $59K | Buy |
165,490
+112,334
| +211% | +$40K | ﹤0.01% | 3642 |
|
2023
Q2 | $17K | Hold |
53,156
| – | – | ﹤0.01% | 3758 |
|
2023
Q1 | $18 | Sell |
53,156
-650
| -1% | – | ﹤0.01% | 3681 |
|
2022
Q4 | $17K | Sell |
53,806
-150
| -0.3% | -$47 | ﹤0.01% | 3611 |
|
2022
Q3 | $23K | Buy |
53,956
+3,706
| +7% | +$1.58K | ﹤0.01% | 3563 |
|
2022
Q2 | $26K | Buy |
+50,250
| New | +$26K | ﹤0.01% | 3549 |
|